Honeywell Files Registration Statement for Aerospace Spinoff Planned in 2026
Honeywell filed its Form 10 registration statement with the U.S. Securities and Exchange Commission for the planned spinoff of Honeywell Aerospace, which is slated to begin trading on the Nasdaq under the ticker "HONA" in Q3 of 2026. Meanwhile, MiniMed opened at $19.05 after pricing its 28M‑share initial public offering at $20, below its targeted $25–$28 range.LATEST IPOS AND DIRECT LISTINGS:MiniMedopened on March 6 at $19.05. The diabetes business subsidiary of Medtronicpriced its initial public offering of 28M shares of its common stock at $20.00, below the target range of $25.00-$28.00.Robinhood Ventures Fund Iopened on March 6 at $22 after pricing its initial public offering of 12,615,608 common shares of beneficial interest at an initial public offering price of $25.00 per share. RVI is a closed-end fund from Robinhoodthat provides retail investors exposure to a concentrated portfolio of private companies.PERFORMANCE:Prices as of 10 am ET on Monday, March 9 -MiniMed – up almost 3% at $18.98;Robinhood Ventures Fund I – up 2% at $21.45.RECENT IPOS TO WATCH:ARKO Petroleum, Solv Energy, AGIare already seeing coverage roll out, while Jaguar Uraniumis among stocks that could see new coverage this week as the quiet periods for banks that underwrote the companies' IPOs expire.UPCOMING IPOS:Upcoming IPO and direct listings expected include Studend Living EduVation, Liftoff, Cerebras Systems, PayPay, and OpenAI.Clickto see upcoming IPO calendar on TipRanks.Student Living EduVation -The companyfiled with the SEC for an initial public offering of 3.75M ordinary shares. The company stated, "We are offering 3,750,000 Ordinary Shares on a firm commitment basis. We anticipate that Offering price of the Ordinary Shares will be between $4.00 and $6.00 per Ordinary Share. The Resale Shareholders are also offering 5,880,000 Ordinary Shares to be sold pursuant to the Resale Prospectus. We are registering the Resale Shares pursuant to the Registration Rights Agreements we entered into with the Six Pre-IPO Investors on September 19, 2025... We will not receive any of the proceeds from the sale of the Ordinary Shares by the Resale Shareholders. Prior to this Offering, there has been no public market for our Ordinary Shares. We intend to apply to list our Ordinary Shares on the Nasdaq Capital Market under the symbol 'SDLV'... We are a Cayman Islands exempted company with limited liability with a principal place of business in Hong Kong through our wholly-owned subsidiary, Student Living Culture Technology Limited. We are a student living and referral of education advisory services provider operating under the "Student Living" brand in Hong Kong. Our mission is to transform student dormitories into incubators for learning, collaboration, and self-discovery, as well as fostering an ecosystem that nurtures future global talent, providing more than just a place to live."Liftoff Mobile announced that it has confidentially submitted a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The total number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market and other conditions and the completion of the SEC's review process.Cerebras Systems– The company has filed confidentially for a U.S. initial public offering, The Information's Valida Pau and Katie Roof. The re-filing comes after a major sales pact with OpenAI, the authors note.PayPay Corporation- The company filed for an initial public offering of American depositary shares, or ADSs, and has applied to list the ADSs on the Nasdaq Global Select Market under the symbol "PAYP." The prospects filed with the SEC states, "As Japan's leading financial technology company, we are dedicated to our goal of becoming a digital finance platform for all... We launched this service in October 2018 and it rapidly expanded to become a nation-wide leading cashless payments ecosystem that had approximately 72 million PayPay registered users as of December 31, 2025, representing a penetration of 75% among 96 million smartphone users in Japan. With the acquisition of PayPay Card Corporation in October 2022, our platform evolved to a next-generation payments ecosystem, seamlessly integrating our code-based payment and credit card payment services through our PayPay app."OpenAI- The is accelerating its plans for a public listing as rivalry with Anthropic intensifies, now planning on listing in Q4 of this year, Berber Jin, Corrie Driebusch, and Kate Clark of The Wall Street Journal. OpenAI is holding discussions with Wall Street banks about a potential initial public offering and has hired several executives to oversee its finance team, sources told the Journal.SpaceX- Elon Musk is targeting mid-June for the timing of SpaceX's initial public offering, IPO, Ivan Levingston, Stephen Morris, and Mercedes Ruehl of The Financial Times, citing five people familiar with the matter. The company is looking to raise $50B at a valuation of $1.5T, the sources added.OTHER IPO NEWS:Honeywellannounced the filing of its Form 10 registration statement with the U.S. SEC for the planned spinoff of Honeywell Aerospace, which will trade on the Nasdaq under the ticker "HONA." The filing represents significant milestone toward Honeywell Aerospace becoming an independent public company in the third quarter of 2026.Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, and upcoming IPOs.
Trade with 70% Backtested Accuracy
Analyst Views on MMED
About MMED
About the author

- Market Volatility Impact: The IPO market faced significant delays in the first quarter of 2026 due to tech sell-offs, tariff issues, private credit concerns, and ongoing conflicts in the Middle East, which caused a sharp decline in new issuances after a strong start.
- Decline in IPO Count: A total of 35 IPOs raised $9.9 billion this quarter, reflecting a drop in deal count from previous periods; however, 22 of these IPOs raised over $100 million, including Forgent, which raised over $1 billion, indicating sustained demand for larger offerings.
- Valuation Multiples Decline: The momentum from last year's tech IPO revival faded as valuation multiples collapsed amid fears of disruption from AI, yet investors still exhibited interest in the market, suggesting a cautious optimism for future opportunities.
- Future Outlook: Despite the current unstable market conditions, there remains investor interest in potential IPO opportunities, and it is anticipated that IPO activities may rebound as market conditions improve.
- Positive Market Outlook: MiniMed (MNMD) shares rose for the first time post-IPO quiet period, despite a ~20% drop since its debut, as analysts express optimism about its future market potential.
- Large Market Size: Wells Fargo issued an Overweight rating, highlighting an $18B market for automated insulin delivery systems with only 7% penetration, indicating significant growth opportunities ahead.
- International Advantage: With operations in ~80 countries and ~70% of revenue generated internationally, analysts believe MiniMed is well-positioned to benefit from expanding global market penetration, further solidifying its market position.
- Significant Competitive Edge: Analysts noted that MiniMed's partnership with Abbott (ABT) starting in CY26 will materially enhance its continuous glucose monitoring systems, providing a key competitive advantage, although some analysts raised concerns about product form factor and usability.
- Visa and Mastercard Ratings: Loop initiates coverage on Visa and Mastercard with a buy rating, anticipating significant net revenue growth driven by market share gains and upside from foreign exchange volatility, enhancing their competitive edge in the payment processing sector.
- Arista and Cisco Buy Ratings: Truist initiates buy ratings for Arista Networks and Cisco, citing their high-quality business scale and thematic attractiveness, particularly in the data center growth space, which presents underappreciated opportunities.
- 10X Genomics Upgrade: William Blair upgrades 10X Genomics from market perform to outperform, highlighting its pivotal role in AI drug discovery and improved profitability, which is expected to drive future growth following five consecutive topline beats.
- MiniMed Platform Outlook: Morgan Stanley initiates MiniMed at overweight with a $19 price target, projecting that its differentiated diabetes management platform will drive growth and margin expansion, particularly given the significant underpenetration in the U.S. market.
- Market Volatility Impact: The IPO market faced significant volatility in Q1 2026 due to tech sell-offs, tariff turmoil, private credit issues, and the war in the Middle East, which grounded new issuance before it could take off.
- Decline in IPO Count: The quarter ended with 34 IPOs raising a total of $9.9 billion, reflecting a notable decrease in deal count compared to previous periods, indicating that market uncertainty is suppressing new issuances.
- Support from Large Offerings: Among the 34 IPOs, 22 raised over $100 million, including Forgent, an electrical equipment maker that raised over $1 billion, demonstrating ongoing investor appetite for larger transactions despite overall market challenges.
- Increased Valuation Pressure: The previous year's tech IPO revival faded as valuation multiples collapsed amid fears of disruption from AI, yet investors still showed some interest in new offerings, highlighting a complex market sentiment.
- Earnings Outlook Downgrade: Medtronic (MDT) has lowered its non-GAAP earnings per share forecast for fiscal 2026 to $5.50 - $5.54 from a previous range of $5.62 - $5.66 due to the recent IPO of its diabetes business MiniMed Group (MMED), indicating significant pressure on profitability.
- IPO Impact Analysis: The public listing of MiniMed (MMED) on March 9 is expected to create a $0.04 per share dilutive effect for Medtronic (MDT), highlighting the direct financial implications of the new listing and potentially undermining investor confidence.
- One-Time Expense Burden: MiniMed (MMED) will incur a one-time charge of $157 million due to payments owed to Blackstone (BX), which will impact earnings by $0.08 per share in Q4 FY26, further exacerbating the company's financial challenges.
- Future Growth Outlook: Despite the current earnings downgrade, Medtronic (MDT) maintains its outlook for high single-digit EPS growth for fiscal 2027, reflecting confidence in the company's long-term growth potential.
- Impact of Crude Prices: Oil drillers and energy stocks have seen significant gains this year due to rising crude prices.
- Geopolitical Factors: The surge in crude prices is primarily attributed to the ongoing war in Iran and concerns over supply constraints.











